secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dermata Therapeutics, Inc. (DRMA)
CIK:        0001853816
Form:       8-K
Filed at:   2025-01-23T23:59:59+00:00
Accession:  0001654954-25-000681
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dermata raises $2.55M private placement at $1.27/unit with insider participation
--------------------------------------------------------------------------------

- Gross proceeds $2.55M; net ~$2.4M from 2,007,880 shares (or pre-funded warrants) and same number of warrants.
- Warrants exercisable at $1.27/share upon stockholder approval and expire five years later.
- Insiders (CEO, CFO, board) purchased ~$1.55M of offering at same $1.27/unit price.
- Net proceeds plus cash expected to fund operations into Q3 2025.
- H.C. Wainwright served as placement agent; resale registration statement to be filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1853816/000165495425000681/0001654954-25-000681-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1853816/000165495425000681/drma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-25-000681

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer